These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15124024)

  • 41. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.
    Garg A; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):687-709. PubMed ID: 17636457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life.
    Gurbaxani B; Dela Cruz LL; Chintalacharuvu K; Morrison SL
    Mol Immunol; 2006 Mar; 43(9):1462-73. PubMed ID: 16139891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mouse MHC class I-like Fc receptor encoded outside the MHC.
    Ahouse JJ; Hagerman CL; Mittal P; Gilbert DJ; Copeland NG; Jenkins NA; Simister NE
    J Immunol; 1993 Dec; 151(11):6076-88. PubMed ID: 7504013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
    Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
    Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.
    Dall'Acqua WF; Woods RM; Ward ES; Palaszynski SR; Patel NK; Brewah YA; Wu H; Kiener PA; Langermann S
    J Immunol; 2002 Nov; 169(9):5171-80. PubMed ID: 12391234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abundant intracellular IgG in enterocytes and endoderm lacking FcRn.
    Mohanty S; Kim J; Ganesan LP; Phillips GS; Robinson JM; Anderson CL
    PLoS One; 2013; 8(7):e70863. PubMed ID: 23923029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
    Gurbaxani B; Dostalek M; Gardner I
    Mol Immunol; 2013 Dec; 56(4):660-74. PubMed ID: 23917469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction.
    Wang Z; Fraley C; Mezo AR
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1253-6. PubMed ID: 23375228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies.
    Vaccaro C; Bawdon R; Wanjie S; Ober RJ; Ward ES
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18709-14. PubMed ID: 17116867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
    Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
    Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histamine 4 receptor plays an important role in auto-antibody-induced arthritis.
    Nent E; Frommholz D; Gajda M; Bräuer R; Illges H
    Int Immunol; 2013 Jul; 25(7):437-43. PubMed ID: 23545338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor.
    Seijsing J; Yu S; Frejd FY; Höiden-Guthenberg I; Gräslund T
    Sci Rep; 2018 Mar; 8(1):5141. PubMed ID: 29572538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity.
    Abdiche YN; Yeung YA; Chaparro-Riggers J; Barman I; Strop P; Chin SM; Pham A; Bolton G; McDonough D; Lindquist K; Pons J; Rajpal A
    MAbs; 2015; 7(2):331-43. PubMed ID: 25658443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
    Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
    MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
    Fiebiger BM; Maamary J; Pincetic A; Ravetch JV
    Proc Natl Acad Sci U S A; 2015 May; 112(18):E2385-94. PubMed ID: 25870292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
    Andersen JT; Justesen S; Berntzen G; Michaelsen TE; Lauvrak V; Fleckenstein B; Buus S; Sandlie I
    J Immunol Methods; 2008 Feb; 331(1-2):39-49. PubMed ID: 18155020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
    Pollastrini J; Dillon TM; Bondarenko P; Chou RY
    Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.
    Hubbard JJ; Pyzik M; Rath T; Kozicky LK; Sand KMK; Gandhi AK; Grevys A; Foss S; Menzies SC; Glickman JN; Fiebiger E; Roopenian DC; Sandlie I; Andersen JT; Sly LM; Baker K; Blumberg RS
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32658257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
    Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
    Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.
    Mandik-Nayak L; Allen PM
    Immunol Res; 2005; 32(1-3):5-13. PubMed ID: 16106055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.